Mizuho cuts Braze stock price target on valuation, keeps Outperform

Braze posted Q1 revenue of $211 million, beating estimates by 2.83%, while EPS of $0.10 matched consensus. The company also raised fiscal 2027 revenue growth guidance to 21.5% from 20.1% and delivered 30% year-over-year revenue growth, its fourth straight quarter of accelerating organic growth. Mizuho still cut its price target to $32 from $40 on multiple contraction, but maintained an Outperform rating amid strong AI product adoption and solid bookings.

Analysis

The market is still pricing BRZE like a decelerating SaaS name, but the operating data argues the opposite: the business is re-accelerating while the valuation multiple is compressing. That mismatch is usually where the best mid-cap software returns come from, because once revenue growth is back above the “good enough” threshold, the market tends to re-rate on durability rather than on current-quarter noise. The key tell is that enterprise demand appears to be broadening rather than just stabilizing, which makes this less about a one-quarter beat and more about a multi-quarter booking inflection.

The more interesting second-order effect is competitive. If AI product adoption is real, BRZE is not just defending share; it is moving higher in the stack from campaign tooling toward decisioning and automation, which increases switching costs and could pressure smaller customer engagement vendors that lack a credible AI roadmap. The customer-success entitlement reclassification also matters: it likely muddies near-term subscription optics while improving the quality of recurring revenue attribution elsewhere, so headline growth may understate underlying retention and expansion momentum.

Consensus appears anchored to multiple compression risk while underappreciating guidance optionality. If management can sustain low-20s growth into the next two quarters, the stock can re-rate simply on the path to Rule-of-40 improvement even without upward estimate revisions. The contrarian risk is that the market may need one more clean quarter to trust the acceleration, so the stock can stay cheap longer than fundamentals imply; any slowdown in enterprise win rates or AI monetization would quickly unwind the re-rating narrative.

Key Decisions for Investors

• Go long BRZE on a 3-6 month horizon; target a move toward the low $30s if growth sustains and the market re-prices the multiple, with downside limited by already-compressed sentiment.
• Use call spreads in BRZE rather than outright equity for the next earnings cycle; upside is tied to continued booking strength, but the stock may remain range-bound until another clean print confirms durability.
• Pair trade: long BRZE / short a slower-growing customer engagement software peer with similar valuation exposure; the spread should work if investors reward accelerating growth over narrative names.
• If BRZE rallies 15-20% before the next quarter, trim into strength and wait for the next data point; this is a fundamentals-improving story, but multiple recovery is likely to be stepwise rather than linear.
• Avoid chasing SMCI or APP on the back of this read-through; the article’s signal is about enterprise software re-acceleration, not a broad AI beta trade.